Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (14)

2023

  1. GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 1, pp. 29-38

2021

  1. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

    Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819

2019

  1. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly

    EBioMedicine, Vol. 43, pp. 537-552

2015

  1. Hypopituitarism After Traumatic Brain Injury

    Endocrinology and Metabolism Clinics of North America, Vol. 44, Núm. 1, pp. 151-159

  2. Update on prognostic factors in acromegaly: Is a risk score possible?

    Pituitary, Vol. 18, Núm. 3, pp. 431-440

2013

  1. Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients

    Clinical Endocrinology, Vol. 78, Núm. 2, pp. 278-284

  2. Signs and Symptoms of Pituitary Disease

    Pituitary Disorders: Diagnosis and Management (Wiley-Blackwell), pp. 13-20

2012

  1. Adenomas hipofisarios no funcionantes

    Medicine (Spain), Vol. 11, Núm. 13, pp. 757-763

2011

  1. Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: Prevalence, evolution of hormone dysfunction and genetic analysis

    Neuroendocrinology, Vol. 93, Núm. 3, pp. 181-188

  2. Somatotroph tumor progression during pegvisomant therapy: A clinical and molecular study

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 2

2010

  1. Hypopituitarism following traumatic brain injury: Determining factors for diagnosis

    Frontiers in Endocrinology, Vol. 2, Núm. AUG

  2. Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 5, pp. 2147-2154

  3. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229

2008

  1. Severe hypertension and hypokalemia as first clinical manifestations in ectopic Cushing's syndrome

    Arquivos Brasileiros de Endocrinologia e Metabologia, Vol. 52, Núm. 6, pp. 1066-1070